Page 5 of 9 SEC Filing CUSIP No. 15130J 109 SC 13D Page 5 of 11
1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Steve Elms 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) o (b) x 3 SEC USE ONLY 4 SOURCE OF FUNDS OO 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) o 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 3,819 8 SHARED VOTING POWER 1,232,278 (including 39,218 shares of the Issuer’s common stock issuable upon the exercise of the Warrants) 9 SOLE DISPOSITIVE POWER 3,819 10 SHARED DISPOSITIVE POWER 1,232,278
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,236,097 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES o 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 2.6% 14 TYPE OF REPORTING PERSON IN
Follow Melinta Therapeutics Inc. W (NASDAQ:MLNT)
Follow Melinta Therapeutics Inc. W (NASDAQ:MLNT)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
| CUSIP No. 15130J 109 | SC 13D | Page 5 of 11 |
| 1 | NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Steve Elms | |
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | (a) o (b) x |
| 3 | SEC USE ONLY | |
| 4 | SOURCE OF FUNDS OO | |
| 5 | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) | o |
| 6 | CITIZENSHIP OR PLACE OF ORGANIZATION United States |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 7 | SOLE VOTING POWER 3,819 |
| 8 | SHARED VOTING POWER 1,232,278 (including 39,218 shares of the Issuer’s common stock issuable upon the exercise of the Warrants) | |
| 9 | SOLE DISPOSITIVE POWER 3,819 | |
| 10 | SHARED DISPOSITIVE POWER 1,232,278 |
| 11 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,236,097 | |
| 12 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES | o |
| 13 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 2.6% | |
| 14 | TYPE OF REPORTING PERSON IN |
Follow Melinta Therapeutics Inc. W (NASDAQ:MLNT)
Follow Melinta Therapeutics Inc. W (NASDAQ:MLNT)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
